Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

GNP LIDOCAINE HCL 4% CREAM

Lidocaine HCl
$0.0514per GM
OTC

Strength

4 g/100g

Manufacturer

AmerisourceBergen

NDC

46122061410

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

LIDOCAINE HYDROCHLORIDE

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M017

On Market Since

2/24/2020

Pharmacological Classes

Amide Local Anesthetic
Amides
Antiarrhythmic
Local Anesthesia

Price History

1W

0.0%

1M

-1.2%

3M

-2.9%

6M

-1.3%

1Y

+6.7%

3Y

+3.8%

5Y

N/A

All

+25.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

BURN RELIEF 0.5% SPRAY
Generic
70000062401•Cardinal Health
$0.0276
per GM
BURN RELIEF 0.5% SPRAY
Generic
46122055528•AmerisourceBergen
$0.0283
per GM
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
60687060365•American Health Packaging
$0.0385
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
50268072815•AvPAK
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
53746027105•Amneal Pharmaceuticals of New York LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023201•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
57237023205•Rising Pharma Holdings Inc.
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089718•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
62135089790•Chartwell RX LLC
$0.0394
per EA
SULFAMETHOXAZOLE-TMP SS TABLET
Generic
65162027110•Amneal Pharmaceuticals LLC
$0.0394
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy